Search
Prenetics Global Ltd
PREAdd to Watchlist
20.500USD
+0.645+3.25%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
263.26MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Prenetics Global Ltd is 8.00, ranking 165 out of 389 in the Biotechnology & Medical Research industry. The average price target is 31.00, with a high of 31.00 and a low of 31.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
31.000
Target Price
+51.22%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Prenetics Global Ltd
PRE
3
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Prenetics Global Ltd's expected revenue for the next quarter?
Prenetics Global Ltd's expected revenue is 45.93M.
What is Prenetics Global Ltd's price target?
Analysts forecast that Prenetics Global Ltd's price target is USD 31.00, with the highest forecast at USD 31.00 and the lowest forecast at USD 31.00.
How have Prenetics Global LtdPRE's recent earnings per share performed?
The market expectation was USD -1.36, while Prenetics Global LtdPRE's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.76.
What is the analyst rating for Prenetics Global Ltd?
Based on the ratings of Prenetics Global Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
